Barrington James

As our US network celebrates Thanksgiving, we want to share a genuine thank you. To our clients for your partnership and the strong relationships that underpin our work. To our candidates for the expertise, ambition and resilience you bring to every opportunity. To our colleagues and partners for the standards you uphold and the care you show every day. From everyone at Barrington James, we wish you a restorative Thanksgiving and time well spent with the people who matter most. #BarringtonJames #Thanksgiving #LifeSciences #Biotech #Pharma #MedTech #MedicalDevices #Biotechnology #LifeSciencesRecruitment #USNetwork #TalentPartners #Gratitude

Swipe through for CDMO Specialist, Austin Hodgson’s BIO 2025 highlights and see how shifting CDMO demand is set to impact your 2025 hiring strategy. • CDMOs are expanding microbial, recombinant, ADC and peptide capabilities, driving demand for hybrid commercial–scientific talent who can position these services with clarity. • APAC organisations are accelerating their European growth plans, increasing the need for locally based BD, alliance and regulatory leaders who can navigate complex global structures. If you are planning senior hires across CDMO business development or technical functions in 2025, connect with Austin Hodgson on LinkedIn or contact our team at help-me-hire@barringtonjames.com Visit our website to discover how we connect technically strong and commercially sharp talent with growth-focused CDMOs: https://lnkd.in/eneS3Hak #BIO #BIO2025 #BarringtonJames #BarringtonJamesUSA #CDMO #LifeSciences #LifeSciencesRecruitment #Pharma #Biotech #BiotechRecruitment #MedTech #MedTechRecruitment #HiringTrends #TalentStrategy #ExecutiveSearch  

Last Friday our EU Managing Director, Matthew Tucker, spent the morning at The College of Richard Collyer’s Sixth Form College in Horsham, speaking with students about employability, CV fundamentals and what hiring managers are really looking for in today’s market. As a global leader in life sciences recruitment, we see every day how preparation, mindset and clarity of story can transform a candidate’s trajectory. Being able to share that perspective with the next generation, in a college with such strong heritage in our local community, felt like a natural extension of our role. Huge thank you to The College of Richard Collyer’s for having us and to the students for their questions and engagement. We are proud to support young people from Horsham as they take their next steps into higher education, apprenticeships and industry. #BarringtonJames #Horsham #EmployabilitySkills #FutureTalent #EarlyCareers #LifeSciencesCareers #CVTips #HiringManagers #CareerDevelopment #CommunityEngagement

After witnessing GLP-1 consolidation and oncology platform bets to ADC focus shots and data-rich diagnostics, this week’s headlines point to concentrated capital and capability across cardiometabolic scale, targeted modalities and emerging tools. In our latest Industry Insights carousel, we highlight: • Pfizer strengthens its position in obesity by securing Metsera, signalling renewed momentum in incretin portfolios and the build-out of medical, safety and access capacity. • Johnson & Johnson acquires Halda’s targeted cell-death platform to deepen its prostate oncology strategy and accelerate translational and clinical development hiring. • Day One moves to acquire Mersana Therapeutics and its B7-H4 ADC, reinforcing the need for tox, bioanalytics and CMC strength as new antigen targets advance. • AHA Scientific Sessions spotlight thermal imaging, photonics and EEG wearables, underscoring SaMD, human factors and real-world evidence capability in prevention-led care. • Sofinnova closes a €650m flagship fund for early-stage life sciences, a positive read-through for European company formation and specialist talent demand into 2026. At Barrington James, we connect biotech and medtech leaders with regulatory, quality, clinical, CMC, access and commercial talent to turn strategy into measurable outcomes at pace. Learn more about our work on our website: https://lnkd.in/eneS3Hak #Biotech #MedTech #LifeSciences #Oncology #Cardiometabolic #ADC #SaMD #RWE #HEOR #MarketAccess #RegulatoryAffairs #PV #CMC #BarringtonJames #LifeSciencesRecruitment

Cardiometabolic scale-ups (GLP-1 portfolios), oncology platform plays (targeted cell-death), the ADC resurgence (B7-H4 and other novel targets) and data-rich diagnostics (SaMD and wearables) are shifting the skills mix fast. We’re seeing elevated demand across Medical Affairs & Safety/PV, Translational & Clinical Development, Tox/Bioanalytics/CMC, Regulatory Affairs & QA, HEOR/Market Access, Biostatistics & RWE, Human Factors/Usability, Product/Data for SaMD, and Tech Ops/CDMO partnership leadership. Vote in the poll and add the hardest role you expect to hire next year and why. #Biotech #MedTech #LifeSciences #Hiring #Talent #GLP1 #Oncology #ADC #SaMD #HEOR #MarketAccess #RWE #RegulatoryAffairs #PV #CMC #BarringtonJames #LifeSciencesRecruitment

Today we recognise the men in our teams, families and communities. Progress relies on environments where men can contribute at their best and feel able to ask for help when it matters. We believe the best results come from cultures that combine accountability, empathy and everyday wellbeing. Holding ourselves to high standards matters, and so does understanding the pressures people carry. By pairing clear targets with human leadership and healthy daily practices, we build teams that deliver today and stay strong for tomorrow 💙 #InternationalMensDay #MensHealth #MentalHealth #EmployeeWellbeing #Leadership #PeopleAndPerformance #WorkplaceCulture #Talent

In light of World Diabetes Day, it’s important to recognize how technology and multidisciplinary teams are reshaping diabetes care. As progress continues, let’s keep the conversation going about what the new standard means for patients, professionals, and everyone who cares. Learn more here: https://lnkd.in/eHJPv-cf

From resilient dental demand and operating discipline to global compliance consolidation and women’s health portfolio reshaping, this month’s medtech headlines directly point to regulatory velocity and platform scale. In our latest Medical Device Insights carousel, we highlight: • Henry Schein raises its 2025 outlook after a Q3 beat, launches a $200m+ efficiency programme, deepens KKR sponsorship to 19.9 percent, and signals strong European dental equipment momentum as it refocuses on growth and resilience. • Registrar Corp acquires CMC Medical Devices to create a single-stop pathway for US, EU and global approvals, meeting rising demand for specialist MDR, IVDR and multi-market compliance support. • Proxima Clinical Research names Eric Ross CEO under new ownership, positioning Houston’s Texas Medical Center as a growing MedTech CRO hub for AI-enabled devices and digital health trials. • Organon divests the Jada postpartum haemorrhage device to Laborie in a deal worth up to $465m, transferring ~100 staff and underscoring the shift of women’s health devices into focused medtech platforms. At Barrington James, we connect medtech leaders with regulatory, quality, clinical, manufacturing and commercial talent to convert strategy into measurable outcomes at pace. Ready to discuss your hiring roadmap? Learn more at our website: https://lnkd.in/dxzZK-Hw #MedTech #MedicalDevices #DigitalHealth #AIinHealthcare #SurgicalRobotics #Orthopaedics #Cardiology #Urology #WomensHealth #IVD #InVitroDiagnostics #DiagnosticImaging #RemotePatientMonitoring #Wearables #HealthTech #DeviceInnovation #MDR #IVDR #CEMarking #FDA510k #PMA #QualityAssurance

ISPOR day 2 complete! It’s been an absolute pleasure meeting up with many candidates, clients & friends! Day 3 is pending, I still have a small amount of availability to meet tomorrow, but the clock is running thin… Drop me a direct message via LinkedIn to claim a slot! Also, thank you for whoever took the photo of me below, I didn’t quite catch your name but it was much appreciated! #findthatperson #ISPOR #ISPOR2025